Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Clasificación en acciones #15371
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Precio por acción
$6.66
Capitalización bursátil
$362.53M
Cambio (1 día)
0.63%
Cambio (1 año)
-61.11%
País
US
Comercio Upstream Bio, Inc. (UPB)

Categoría

Ratio P/B de Upstream Bio, Inc. (UPB)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Upstream Bio, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Upstream Bio, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.828 -
US
7.5116 -
NL
3.9942 -
AU
8.2199 -
US
- -
CH